• BEHAVIORAL PHARMACOLOGY HOME

    Welcome! This is the location for news about our Division and information on our membership, governance, careers in Behavioral Pharmacology and more!


    Recent News and Announcements...

  • Behavioral Pharmacology at EB 2012

    The following symposia are scheduled for EB 2012...


    New USDA Guidlines : Responses Requested by April 24, 2011

    At this year’s ASPET meeting, we discussed the new USDA Guidelines and how disruptive those guidelines will be to researchers.  Please review Nancy Ator's slides and respond directly to the UDSA with your comments.

    View/Download: Powerpoint Slides | PDF


    EB 2011 Meet and Greet

    Following the ASPET poster competition, all Behavioral Pharmacology Division competitors were invited to our Meet and Greet Event. This is an opportunity for predocs and postdocs to network with their peers and established scientists from academia, government, industry, and scientific publishing. We would like to thank Targacept, Covance, and Med Associates for generously sponsoring this event.


    Winners of the 2011 Behavioral Pharmacology Division Poster Competition

    First place (postdoc): Lindsey Hamilton (United States Army Medical Research Institute of Chemical Defense); Second place (postdoc): Kevin Murnane (Emory University); First place (predoc): Michelle Baladi (University of Texas Health Science Center; Second place (predoc): Jeremiah Bertz (University of Michigan)


    Behavioral Pharmacology at EB 2011

    The following ASPET and Behavioral Pharmacology Division symposia were scheduled for the annual meeting..."

     

  • About the Division...

    The Division of Behavioral Pharmacology serves members interested in research on the behavioral effects of drugs. These interests range from behavioral approaches to the study of CNS pharmacology to investigations of how drugs alter behavior and encompass perspectives that range from descriptive to mechanistic. Most often, behavioral pharmacologists examine drugs with an emphasis on effects in the whole organism, and with an appreciation of the considerable influence of environmental variables on drug action. Areas of interest include (but are not limited to): effects of centrally active drugs on conditioned or unconditioned behavior, application of receptor theory to behavioral pharmacology, pharmacological aspects of drug abuse, use of animal models to aid in the discovery and development of new pharmacological agents to treat CNS or psychiatric disorders, drug interactions, the effects of repeated or chronic exposure to drugs, and the use of pharmacological tools in the analysis of behavior.